Delayed insulin transport across endothelium in insulin-resistant JCR:LA-cp rats

被引:16
|
作者
Wascher, TC
Wölkart, G
Russell, JC
Brunner, F [1 ]
机构
[1] Karl Franzens Univ Graz, Inst Pharmakol & Toxikol, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria
[2] Karl Franzens Univ Graz, Dept Internal Med, Diabet Angiopathy Res Grp, A-8010 Graz, Austria
[3] Univ Alberta, Med Res Ctr, Dept Surg, Edmonton, AB, Canada
关键词
D O I
10.2337/diabetes.49.5.803
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Capillary endothelial cells are thought to limit the transport of insulin across the endothelium, resulting in attenuated insulin action at target sites. Whether endothelial insulin transport is altered in dysglycemic insulin-resistant states is not clear and was therefore investigated in the JCR:LA-cp corpulent male rat, which exhibits the metabolic syndrome of obesity, insulin resistance, hyperlipidemia, and hyperinsulinemia. Lean littermates that did not develop these alterations served as controls. Animals of both groups mere normotensive (mean arterial pressure 136 +/- 2 mmHg). Hearts from obese and lean rats aged 7 (n = 6) or 18 (n = 8) weeks were perfused in vitro at 10 ml/min per gram wet wt over 51 min with Krebs-Henseleit buffer containing 0.1 or 0.5 U human insulin/l (equivalent to 0.6 and 3 nmol/l), Interstitial fluid was collected using a validated method, and interstitial insulin was determined with a radioimmunoassay. At 0.1 U/l, insulin transfer velocity was similar in both experimental groups (half-times of transfer: 11 +/- 0.2 min in obese and 18 +/- 4 min in lean rats; NS), but at 0.5 U/l, the respective half-times were 7 +/- 1 min in lean and 13 +/- 2 min in obese rats (P < 0.05). The steady-state level of insulin in the interstitium was 34 +/- 1% of the vascular level at 0.1 U/l and reached the vascular level (102 +/- 2%) at 0.5 U/l in both lean and obese rats. In rats aged 18 weeks, the half-times of insulin transfer mere 31 +/- 2 and 14 +/- 1 min in obese rats and 10 +/- 0.3 and 7 +/- 0.3 min in lean rats (P < 0.05). Again, interstitial steady-state levels were similar in both groups. Finally postprandial insulin dynamics were simulated over a period of 120 min with a peak concentration of 0.8 U/l in rats aged 27 weeks (n = 4). The maximal interstitial level mas 0.38 +/- 0.02 U/l in lean rats and 0.24 +/- 0.02 U/l in obese rats (P < 0.05), and a similar difference was noted throughout insulin infusion (areas under the transudate concentration-time curves: 17 and 11 U/min per l, respectively). These data show, for the first time in a genetic animal model of insulin resistance, that transfer of insulin across the endothelium is substantially delayed in obese insulin-resistant rats and that it likely contributes to the postprandial alterations of glucose metabolism observed in the metabolic syndrome.
引用
收藏
页码:803 / 809
页数:7
相关论文
共 50 条
  • [1] Postischemic cardiac performance in the insulin-resistant JCR : LA-cp rat
    Maddaford, TG
    Russell, JC
    Pierce, GN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 273 (03): : H1187 - H1192
  • [2] Cardiac myofibrillar and sarcoplasmic reticulum function are not depressed in insulin-resistant JCR:LA-cp rats
    Misra, T
    Gilchrist, JSC
    Russell, JC
    Pierce, GN
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (06): : H1811 - H1817
  • [3] Vascular wall function in insulin-resistant JCR:LA-cp rats:: Role of male and female sex
    O'Brien, SF
    Russell, JC
    Dolphin, PJ
    Davidge, ST
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (02) : 176 - 181
  • [4] Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats
    Wang, ZQ
    Zhang, XH
    Russell, JC
    Hulver, M
    Cefalu, WT
    [J]. JOURNAL OF NUTRITION, 2006, 136 (02): : 415 - 420
  • [5] Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats
    McKendrick, JD
    Salas, E
    Dubé, GP
    Murat, J
    Russell, JC
    Radomski, MW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (02) : 361 - 369
  • [6] Beneficial insulin-sensitizing and vascular effects of s15261 in the insulin-resistant JCR:LA-cp rat
    Russell, JC
    Ravel, D
    Pegorier, JP
    Delart, P
    Jochemsen, R
    O'Brien, SF
    Kelly, SE
    Davidge, ST
    Brindley, DN
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (02): : 753 - 760
  • [7] Vasculopathy and insulin resistance in the JCR:LA-cp rat
    Russell, JC
    Schmidt, AM
    Graham, SE
    DeReske, M
    Richardson, M
    [J]. ATHEROSCLEROSIS, 1997, 134 (1-2) : 315 - 316
  • [8] Vasculopathy and insulin resistance in the JCR:LA-cp rat
    Richardson, M
    Schmidt, AM
    Graham, SE
    Achen, B
    DeReske, M
    Russell, JC
    [J]. ATHEROSCLEROSIS, 1998, 138 (01) : 135 - 146
  • [9] Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats
    Russell, J. C.
    Kelly, S. E.
    Vine, D. F.
    Proctor, S. D.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (06) : 1588 - 1596
  • [10] MEDICA 16 inhibits hepatic acetyl-CoA carboxylase and reduces plasma triacylglycerol levels in insulin-resistant JCR:LA-cp rats
    Atkinson, LL
    Kelly, SE
    Russell, JC
    Bar-Tana, J
    Lopaschuk, GD
    [J]. DIABETES, 2002, 51 (05) : 1548 - 1555